
NX Group Unveils Global Campaign Visual and Concept Movie
- "Anything to Anywhere" ExpressesNX Group\'s Strengths in Global Transport of Everything from Semiconductors to Museum Exhibits -
NX Group Unveils Global Campaign Visual and Concept Movie
- "Anything to Anywhere" ExpressesNX Group\'s Strengths in Global Transport of Everything from Semiconductors to Museum Exhibits -
Infosys Launches Open-Source Responsible AI Toolkit to Enhance Trust and Transparency in AI
The initiative furthers Infosys\' commitment to creating an inclusive AI ecosystem,ensuring safety,security,privacy,and fairness
SINGAPORE,Feb. 26,2025-- AI/ML health tech startupRespiree has received clearance from the Health Sciences Authority (HSA) to extend its RS001 cardio-respiratory wearable to pediatric populations. Th
SURABAYA,Indonesia,Feb. 26,2025-- As the holy month of Ramadan approaches,The Westin Surabaya and Four Points by Sheraton Surabaya,Pakuwon Indah invite guests to embark on "The Journey of Blessin
Hyundai Motor and Samsung Unveil Breakthrough Private 5G RedCap Technology for Smart Manufacturing
Hyundai Motor and Samsung collaborate to verify Private 5G (P-5G) RedCap technology,enabling fast,seamless communication with lower power consumption and cost
Hikvision earns IEC 62443-4-1 certification for secure product development
HANGZHOU,China,Feb. 26,2025-- Hikvision has successfully achieved IEC 62443-4-1 certification for its product development lifecycle process. IEC 62443-4-1 is a cybersecurity standard specifying requir
10T Tech Unveils Another eSIM Industry First: Multi-SM-DP+ As Standard
BARCELONA,Spain,Feb. 27,2025-- 10T Tech,a global leader ineSIM Orchestration,has taken a huge leap forward in how eSIM solutions are delivered to mobile carriers. Today,in the lead up to Mobile World
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment,greater flexibility,and significant workflow
AIM Vaccine's mRNA RSV Vaccine Approved for U.S. Clinical Trials
Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co.,Ltd.(a joint stock company incorporated in the People\'s Republic of China with limited liability)(Stock Code: 6660.HK)HONG
PORT MELBOURNE,Australia and JOHNSON CITY,Tenn.,Feb. 24,2025-- LabConnect and Australian Clinical Labs\' (ACL) Specialised Trials have forged a strategic partnership to expand support of clinical tr